Tractian's $1.4 billion round prices physical AI at 14 times revenue
Sapphire Ventures' $130 million Series D values Tractian at $1.4 billion, about 14 times the factory-sensor company's roughly $100 million annualized revenue, with Brazilian public money and a Nvidia chip order inside the funding story.
Vincent Jiang · 3 min read
Igor Marinelli grew up watching his father keep paper-mill machines alive with tools he calls backwards, and built Tractian to replace them 1. On October 22 the Atlanta company raised a $130 million Series D at a $1.4 billion valuation, led by Sapphire Ventures and co-led by Catalyst, the growth arm of the British insurer M&G, which invests from a £138 billion with-profits fund, the pooled pot of British policyholders' money, alongside the British Business Bank 1.
More than 2,000 critical facilities run its vibration and ultrasound sensors, including plants of Eli Lilly−2.43% — Eli Lilly, down 2.43 percent today, Coca-Cola and Embraer 1, and Brazilian reporting ranks it Latin America's most valuable AI startup, past the legal-AI firm Enter, marked at $1.2 billion in May 2.
The math the release left out
A $1.4 billion mark on annualized revenue of roughly $100 million, about half of it earned in the United States, per Marinelli, works out to about 14 times sales 2. The Information, which first reported the round, put the figure past $100 million last month 3.
Spread over more than 700 employees, that is roughly $143,000 of revenue per head 12. Forbes counted 200 employees and a $205 million valuation in April 2024 4; the December 2024 Series C, $120 million led by Sapphire, valued the company near $650 million, with 400 staff and 100,000 sensors in the field 52.
Tractian's valuation has more than doubled in under two years
- Estimate
Data
| Value | |
|---|---|
| Apr 2024 (estimate) | $205M |
| Dec 2024 (estimate) | $650M |
| Oct 2026 | $1,400M |
Public money and Nvidia chips inside
Two facts the English-language wires dropped. In August 2026 Tractian signed R$120.1 million from BNDES, Brazil's national development bank, to build robotic inspection assistants, a project running to June 2028 with plans to hire 421 people, 150 of them in research 6.
The Series D itself funds five years of R&D, part of it for training large language models and buying Nvidia−0.19% — Nvidia, down 0.19 percent today processors 2. The demand case is the company's own citation: Siemens pegs unplanned downtime at about 11% of revenue across the 500 largest industrial companies, $1.4 trillion a year, on machines averaging 24 years old 17; Deloitte projects 2.1 million unfilled US manufacturing jobs by 2030 1.
Revenue per head decides the next mark
The bull case is straightforward: Sapphire partner Anders Ranum says the platform "gets sharper with every machine it monitors" 1, and Marinelli expects cash generation before the end of 2027 2. Machine health already had a unicorn, Israel's Augury, which crossed the line in 2021 on a $180 million Series E and is still private, raising $75 million in a 2025 Series F 8.
Every mark in this trade so far is private: Augury, Enter, Tractian. None of the three lists, so on that record exposure runs through the named buyers, Eli Lilly to Embraer, and through Nvidia, whose processors this round buys 2.
The tell at the next mark is revenue per head. If it climbs toward software levels, Tractian has earned a software price. If it stays near $143,000, the investor who pays the next software multiple for an instrument maker is the one who loses.
Get Deals by email, free
The acquisitions, rounds and contracts that move AI money. In our daily email, every weekday.
